title: Producing, controlling, and stabilizing Pasteur's anthrax vaccine: creating a new industry and a health market.
abstract: When Pasteur and Chamberland hastily set up their small biological industry to meet the agricultural demand for the anthrax vaccine, their methods for preparation and production had not yet been stabilized. The process of learning how to standardize biological products was accelerated in 1882 when vaccination accidents required the revision of production norms as the first hypotheses on fixity, inalterability, and transportability of vaccines were invalidated and replaced by procedures for continuous monitoring of the calibration of vaccines and the renewal of vaccine strains. Initially, the incompleteness and ongoing development of production standards justified Pasteur's monopoly on the production of the anthrax vaccine under his immediate supervision. Later on, the Pasteur Institute maintained control of these standards in the framework of a commercial monopoly that it established on the veterinary vaccines first sent and then cultivated abroad by the Société de Vulgarisation du Vaccin Charbonneux Pasteur, founded in 1886.
authors.affiliation: CNRS.
authors.forename: Maurice
authors.initials: M
authors.lastname: Cassier
mesh_terms: D000818:Animals; D000881:Anthrax / Q000266:history* / Q000517:prevention & control / Q000662:veterinary; D022122:Anthrax Vaccines / Q000096:biosynthesis / Q000266:history* / Q000592:standards; D004345:Drug Industry / Q000266:history*; D005602:France; D049672:History, 19th Century; D011786:Quality Control
chemical_list: D022122:Anthrax Vaccines